Characteristics | Total (n = 257) | Non-responders (n = 87) | Responders (n = 170) | P-value |
---|---|---|---|---|
Sex(female) | 223 (86.80) | 73 (83.90) | 150 (88.20) | 0.273 |
Age (years) | 56.20 ± 11.84 | 55.23 ± 10.97 | 56.74 ± 12.31 | 0.336 |
BMI | 22.22 (20.44–24.09) | 21.64 (19.56–24.23) | 22.60 (20.70–24.23) | 0.141 |
F-UDCA | 235 (91.40) | 80 (92) | 155 (91.20) | 0.822 |
Cirrhosis | 83 (31.90) | 33 (37.90) | 49 (28.80) | 0.147 |
Fatigue | 18(7.0%) | 8(9.20%) | 10(5.90%) | 0.439 |
Pruritus | 36(14.0%) | 13(14.90%) | 23(13.50%) | 0.850 |
Comorbidities | Â | Â | Â | Â |
    Hypertension | 29 (11.30) | 5 (5.75) | 24 (14.12) | 0.043 |
    Thyroid disease | 50 (19.50) | 11 (12.64) | 39 (22.94) | 0.046 |
    Atherosis | 5 (1.90) | 4 (4.60) | 1 (0.59) | 0.028 |
Complications | Â | Â | Â | Â |
    Esophageal and gastric varices | 46 (17.90) | 23 (26.44) | 23 (13.53) | 0.011 |
    Ascites | 39 (15.20) | 20 (22.99) | 19 (11.18) | 0.038 |
Laboratory date | Â | Â | Â | Â |
    Albumin (g/l) | 36.90 (32.00–41.35) | 33.80 (28.30–38.60) | 38.20 (33.60–42.65) | < 0.001 |
    Globulin (g/l) | 35.13 ± 7.70 | 36.49 ± 7.80 | 34.45 ± 7.59 | 0.045 |
    Total bilirubin (umol/l) | 25.00 (15.5–49.30) | 36.70 (24.40–70.10) | 19.60 (13.60–34.35) | < 0.001 |
    Alanine aminotransferase (×ULN) | 60.00 (32.00–104.00) | 75.00 (41.00–103.00) | 51.00 (27.00–103.00) | 0.019 |
    Aspartate aminotransferase(×ULN) | 69.00 (42.00–117.00) | 88.00 (71.00–130.00) | 54.00 (35.00–105.00) | 0.010 |
    Alkaline phosphatase (×ULN) | 220.00 (132.00–347.50) | 395.00 (259.00–549.00) | 160.00 (113.00–233.50) | < 0.001 |
    γ-Glutamyl transferase (×ULN) | 206.00 (77.00–421.50) | 400.00 (201.00–709.00) | 159.00 (49.50–311.00) | < 0.001 |
    Total cholesterol (mmol/l) | 4.83 (3.90–6.06) | 57.90 (24.10–170.60) | 21.30 (8.35–68.80) | < 0.001 |
    HDL-C (mmol/l) | 1.28 (0.93–1.68) | 1.29 (0.85–1.91) | 1.26 (0.99–1.64) | 0.676 |
    LDL-C (mmol/l) | 2.74 (2.09–3.64) | 3.16 (2.32–4.72) | 2.54 (1.95–3.33) | < 0.001 |
    White blood cell (× 109/l) | 4.88 (3.59–5.97) | 4.85 (3.82–6.39) | 4.88 (3.58–5.74) | 0.287 |
    Neutrophil counts (×109/l) | 2.75 (1.92–3.65) | 2.91 (2.12–4.28) | 2.58 (1.89–3.44) | 0.017 |
    Lymphocyte counts (109/l) | 1.48 (1.04–1.92) | 1.38 (1.03–1.78) | 1.53 (1.06–2.05) | 0.070 |
    Monocyte counts (×109/l) | 0.31 (0.23–0.40) | 0.31 (0.23–0.41) | 0.31 (0.24–0.40) | 0.885 |
    NLR | 1.83 (1.27–2.76) | 2.16 (1.43–3.33) | 1.70 (1.18–2.53) | 0.001 |
    Platelet count (×109/l) | 150.00 (93.50–225.00) | 150.00 (85.00–228.00) | 153.00 (95.50–222.00) | 0.722 |
    International normalized ratio | 1.05 ()0.95–1.19 | 1.02 (0.92–1.18) | 1.05 (0.97–1.20) | 0.076 |
    APTT(s) | 35.80 (31.70–39.70) | 37.29 ± 7.29 | 34.76 ± 6.10 | 0.004 |
    Serum creatinine (umol/l) | 58.00 (50.00–66.00) | 54.00 (46.00–62.00) | 60.00 (54.00–66.00) | < 0.001 |
    Serum sodium (mmol/l) | 139.80 (137.73–14,158) | 139.10 (137.20–141.00) | 140.30 (138.30–142.00) | 0.008 |
    Positive AMA-2 | 132 (51.40) | 49 (56.32) | 83 (48.82) | 0.274 |
    SP100 | 25(9.70) | 9(10.34) | 16(9.41) | 0.823 |
    GP210 | 64(24.90) | 27(31.03) | 37(21.76) | 0.110 |